
United States · Insurance startup
medZERO, Inc. is a fintech company based in Portland, Oregon, specializing in an employer-sponsored "Buy Now, Pay Later" platform.
Funding reportedLast round: Seed
medZERO, Inc. is a fintech company based in Portland, Oregon, specializing in an employer-sponsored "Buy Now, Pay Later" platform.
This platform offers zero-interest, zero-fee loans to employees for out-of-pocket healthcare expenses, including care for both humans and pets from any provider. Founded by professionals with backgrounds in employee wellness and healthcare benefits, medZERO aims to enhance the accessibility and affordability of healthcare through integration with employer benefit plans and payroll systems. The company's mobile lending platform provides instant financing for healthcare costs without requiring a credit check. Key features include seamless integration with various benefits plans and the ability to utilize pre-tax HSA savings. By offering loans for a wide range of healthcare services, medZERO helps employees manage their expenses while promoting better health outcomes and financial wellness. The platform is designed to address challenges such as rising healthcare costs and high-deductible plans, ultimately supporting healthier and more productive teams for employers.
Funding, as reported
From medZERO, Inc.'s own website: 1 founder, 3 on the team.
What they build
Known for
health carepet healthcare financinginterest-free medical loanshsa integrationinsurance & employee benefit fundsinstant approvalno feesinformation technology & servicesfinancial servicesfinanceemployee benefits platformhospital & health carefinancial stress reliefhealthcare payment solutionsb2cfintech
Built with from their website
PlaidAdobeAmazon SESGoogle Tag ManagerWordPress.orgAtlassianFont AwesomeElementorYouTubeCloudFlare
Viewport MetaGoogle PlaySite KitAdobe Experience ManagerAmazon Simple Email ServiceHubspotBabelPriority Hints
Add your raise, your deck and your story, and put medZERO, Inc. in front of investors. Or tell us what we have wrong.